Urgent.News

What's breaking now, across thousands of outlets.

More in Business

Young Poong and MBK Seek Korea Zinc Injunction

Youngpoong and MBK Partners have requested the court to suspend the duties of six directors, including the chief executive officer of Korea Zinc. This is a follow-up measure after a first instance court ruling that the resolution to appoint them at the annual general meeting of shareholders last yea

Celltrion Extends Biosimilar Lead Across Asia

Celltrion is solidifying its dominance in the Asian region, a representative pharmerging (emerging pharmaceutical) market, driven by the overwhelming market share of its flagship product lineup for autoimmune diseases and anticancer treatments.Celltrion announced on Nov. 19 that it is maintaining th

  • Celltrion maintains 95% market share in Singapore for autoimmune treatment Remsima.
  • Herzuma ranks first in Hong Kong, Thailand, and Malaysia for breast and gastric cancer.
  • Truxima secures 92% market share in Singapore for blood cancer treatment.

More from Thursday 19 November →